2022
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial
Chey WD, Mégraud F, Laine L, López LJ, Hunt BJ, Howden CW. Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial. Gastroenterology 2022, 163: 608-619. PMID: 35679950, DOI: 10.1053/j.gastro.2022.05.055.Peer-Reviewed Original ResearchConceptsEradication rateHelicobacter pylori infectionTriple therapyDual therapyPylori infectionProton pump inhibitor-based triple therapyTreatment-emergent adverse eventsInhibitor-based triple therapyPotassium-competitive acid blockerEfficacy of vonoprazanH pylori eradicationPhase 3 trialOverall study populationAmoxicillin-resistant strainsClarithromycin-resistant strainsH pylori infectionTreatment-naïve adultsPylori eradicationAdverse eventsSecondary outcomesPrimary outcomeStandard treatmentClinical trialsStudy populationAcid blocker
2005
Clinical Utility of Diagnostic Tests for Constipation in Adults: A Systematic Review
Rao S, Ozturk R, Laine L. Clinical Utility of Diagnostic Tests for Constipation in Adults: A Systematic Review. The American Journal Of Gastroenterology 2005, 100: ajg2005283. PMID: 15984989, DOI: 10.1111/j.1572-0241.2005.41845.x.Peer-Reviewed Original ResearchConceptsBlood testsDiagnostic testsSystematic reviewAnorectal manometry studyDiagnosis of constipationRetrospective endoscopic studySlow transit constipationAbdominal X-rayBalloon expulsion testColonic transit studyTransit constipationAnorectal manometryColonic transitEndoscopic studyBalloon expulsionBarium enemaProspective studyExpulsion testPhysiologic abnormalitiesHistorical controlsConstipationManometry studiesStudy populationAlarm featuresMethodological quality
2000
How to explain outcome differences in dyspepsia studies
Fennerty M, Laine L. How to explain outcome differences in dyspepsia studies. 2000, 421-425. DOI: 10.1007/978-94-011-3927-4_44.ChaptersNon-ulcer dyspepsiaPylori infectionAdequate observation periodPlacebo-controlled trialPeptic ulcer diseaseCause of symptomsH. pylori infectionHelicobacter pylori infectionClinical treatment trialsMajor aetiological factorUlcer diseaseTreatment trialsUpper abdomenAetiological factorsEarly trial resultsStudy populationOutcome differencesEpidemiological studiesH. pyloriDyspepsiaDiscordant resultsTrial resultsObservation periodSerious methodological deficienciesTrials